Regeneron Pharmaceuticals (Nasdaq: REGN) will supply an additional 1.25M treatment courses of an antibody cocktail composed of casirivimab and imdevimab
Moderna has received a six-month, $1.97B contract modification from the U.S. Army to manufacture 100M more doses of the company's…
Pfizer has entered into an agreement with the departments of Health and Human Services and Defense to provide 100M more…
Merck (NYSE: MRK) has reached a $356M deal with the departments of Defense and Health and Human Services to further…
Eli Lilly and Co. (NYSE: LLY) has received a potential $375M contract from the departments of Defense and Health and…
AstraZeneca has secured a $486M contract from the departments of Health and Human Services and Defense to further develop and test…
Ology Bioservices has won a one-year, $106.3M reserve production capacity contract from the U.S. Army Contracting Command for more than…
The Centers for Disease Control and Prevention will move to exercise an option under a 2016 contract with Irving, Texas-based health care…
The departments of Health and Human Services and Defense have signed a potential $1.5B agreement with Moderna to produce 100M…
Johnson & Johnson (NYSE: JNJ) has received $1B in U.S. government funding for large-scale production of a potential COVID-19 vaccine…
